Answers are grounded in this paper and cite their sources.
Technical note publishes thresholds and classifications of 60 blood markers for consumers, highlighting their application and guidelines.
BloodMarker is a consumer reference tool that explains individual blood test values in plain language, by locating a submitted value within a fixed set of named bands per marker. Consumer tools of this kind rarely publish the thresholds they apply. This technical note publishes that table in full for 60 markers across 17 panel groupings, in conventional US units. It documents the classification method, identifies which cutpoints correspond to a named published guideline and which do not, and explicitly discloses where the tool's bands depart from the guideline they otherwise follow. Six markers have cutpoints traceable to and verified against a specific guideline: LDL cholesterol, total cholesterol, triglycerides and HDL cholesterol against NCEP ATP III, and fasting glucose and haemoglobin A1c against the ADA Standards of Care. For these, the abnormal and upper bands reproduce the guideline cutpoints exactly, while the tool adds finer sub-bands and, in several cases, a low-end band flagged as a concern that the guideline does not define. Those additions are identified as editorial and not as recognised diagnostic thresholds. The remaining 54 markers use conventional adult laboratory reference ranges for which no single authoritative source is claimed. The document is generated directly from the project's marker data, so the published table cannot drift from the thresholds in use. It is released so that the thresholds behind a public-facing tool are inspectable rather than implicit. It is not clinical guidance and confers no diagnostic authority.
No takes yet. Share an insight, caveat, or question.
BloodMarker Team (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: